Table 1.
Patients' characteristics
| Normal values | PBC | Controls | |
|---|---|---|---|
| Number of patients | 20 | 20 | |
| Females, n (%) | 18 (90%) | 17 (85%) | |
| Age, median (range) | 49 (21–62) | 55 (32–64) | |
| %AMA+ | 100% | 0% | |
| Stage II (Ludwig) | 13 (65%) | n.a. | |
| Stage III (Ludwig) | 7 (35%) | n.a. | |
| ALP (median, range) | 35–129 U/l | 165 (120–320) | 89 (40–144) |
| TBL (median, range) | <1·3 mg/dl | 1·2 (0·6–2·2) | 0·6 (0·4–1·2) |
| γGT (median, range) | 5–36 U/l | 44 (22–120) | 34 (22–56) |
| SGOT (median, range) | <31 U/l | 55 (30–144) | 44 (19–140) |
| SGPT (median, range) | <31 U/l | 68 (44–220) | 64 (24–93) |
γGT: gamma-glutamyl transferase; ALP: alkaline phosphatase; ALT: alanine aminotransferase; AST: aspartate aminotranfrerase; n.a.: not applicable; TBL: total bilirubin; PBC: primary biliary cirrhosis; SGOT: serum glutamic oxaloacetic transaminase; SGPT: serum glutamic pyruvic transaminase; AMA: anti-mitochondrial antibodies.